1 year return (CAGR)
-86.33%
Elevation Oncology Inc Exchange (NASDAQ, USD)
ELEV
-
-0.01 (-2.12%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-35.65%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
21.63M
Price/Sales
372.88
Ent value
10.37M
Price/Book
0.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.37 |
| Daily high | 0.38 |
| Daily low | 0.35 |
| Daily Volume | 4.82M |
| 1y analyst estimate | 0.41 |
| Beta | 1.50 |
| EPS (TTM) | -0.71 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ELEV | S&P500 | |
| Current price drop from All-time high | -97.73% | -0.07% |
| Highest price drop | -98.55% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -83.47% | -10.68% |
| Avg time to new high | 170 days | 12 days |
| Max time to new high | 1012 days | 1805 days |
News
No items found